Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2012
10/18/2012US20120263702 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis
10/18/2012CA2832933A1 Methods for treating bacterial infection
10/18/2012CA2827739A1 Prostate cancer therapy with hsp90 inhibitory compounds
10/17/2012EP2511298A2 Compositions and Methods for Diagnosing and Treating Cancer
10/17/2012EP2510949A1 Therapeutic agent for fibromyalgia
10/17/2012EP2510948A1 T cell activation inhibitor, pharmaceutical composition containing same, and screening method for t cell activation inhibiting substance
10/17/2012EP2510929A1 Methods for treating bacterial infection
10/17/2012EP2510811A2 Use of nutritional compositions for preventing disorders
10/17/2012EP2509619A2 Treatment methods utilizing stem cell mobilizers and immunosuppressive agents
10/17/2012EP2509618A2 Systemic administration of an agent that permeabilises tumour vasculature
10/17/2012EP2509601A1 Small pyrimidine derivatives and methods of use thereof
10/17/2012EP2509597A1 Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents
10/17/2012EP2509595A1 Inhibitors of hemopoietic cell kinase (p59-hck) and their use in the treatment of influenza infection
10/17/2012EP2509584A1 Pharmaceutical composition for treating cutaneous burns
10/17/2012EP1631255B1 Drug delivery system
10/17/2012CN1922171B Pyrimidine derivative
10/17/2012CN1684701B Ophthalmologic irrigation solutions and method
10/17/2012CN102740890A Transdermal preparation containing basic anti-inflammatory agent
10/17/2012CN102740864A Argon-based inhalable gaseous medicament against peripheral organ deficiencies or failures
10/17/2012CN102740839A Immediate release tablet formulations
10/17/2012CN102740706A Compositions including pyruvate for companion animals and methods of use thereof
10/17/2012CN102733088A Thermo-sensitive poly N-isopropylacrylamide/polyurethane medicine-loading electro-spun fibrous membrane and preparation method thereof
10/17/2012CN102732608A Marker for diagnosing liver cancer and application thereof
10/17/2012CN102732550A Expression of human s1CD80 protein in Pichia pastoris system
10/17/2012CN102732515A Nucleotide sequence and application thereof
10/17/2012CN102731405A Photodynamic treatment medicament, medical composition and preparation method thereof
10/17/2012CN102727896A D-amino-acid oxidase inhibitor for preventing and/or reversing opioid tolerance
10/17/2012CN102727895A Pharmaceutical composition for targeting treatment of intractable epilepsy
10/17/2012CN102727894A Pharmaceutical composition for treating diabetes and its complications and application thereof
10/17/2012CN102727498A Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha
10/17/2012CN102727484A Use of silymarin in preparations of drugs for treatment of Alzheimer's disease
10/17/2012CN102727462A Pharmaceutical formulation comprising microcapsules of statins suspended in alkyl esters of polyunsaturated fatty acids (pufa)
10/17/2012CN102727456A Orally disintegrating tablet of poorly water-soluble drugs and method for preparing orally disintegrating tablet
10/17/2012CN102727437A Liposome treatment of viral infections
10/17/2012CN102210658B Microcapsule soft capsule preparation with high alpha-linolenic acid content
10/17/2012CN102105152B Therapeutic combination comprising a cdks inhibitor and an antineoplastic agent
10/17/2012CN101991852B Application of miR-494 inhibitor in preparing preparation for resisting bone calcium loss and promoting bone formation
10/17/2012CN101495146B Muscle regeneration promoter
10/17/2012CN101141982B Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen
10/16/2012US8288359 Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides
10/16/2012US8288338 Exendin and exendin agonists for eating disorders
10/16/2012US8287918 Medicament for treating lung cancer
10/16/2012US8287894 Hyaluronan as a drug pre-sensitizer and chemo-sensitizer in the treatment of disease
10/16/2012US8287887 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same
10/16/2012US8287886 Tuberculosis vaccine
10/16/2012US8287879 Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
10/16/2012US8287873 Vascular endothelial cell growth factor antagonists and uses thereof
10/16/2012US8287849 Biodegradable poly(beta-amino esters) and uses thereof
10/16/2012US8287847 Administering potassium binding polymer of alpha-fluoroacrylic acid comprising counterion of calcium crosslinked with divinylbenzene, (m)ethylenebisacrylamide, N,N'-bis(vinylsulfonylacetyl) ethylene diamine, 1,3-bis(vinylsulfonyl) 2-propanol, vinylsulfone, polyvinyl ether, polyallylether; hyperkalemia
10/16/2012CA2557324C Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
10/16/2012CA2519253C Carnitine retention
10/16/2012CA2446781C Coated granules based on angiotensin-converting enzyme inhibitor
10/16/2012CA2439763C Pharmaceutical compositions based on anticholinergics and pde-iv inhibitors
10/16/2012CA2419404C Compositions and methods for treating sexual dysfunction
10/16/2012CA2404340C Methods of blocking tissue destruction by autoreactive t cells
10/16/2012CA2364300C A skin care composition that mediates cell to cell communication
10/11/2012WO2012138224A1 Food composition for intra-operative tube feeding
10/11/2012WO2012138212A1 Food composition for intra-operative tube feeding
10/11/2012WO2012137885A1 Agent for inhibiting or preventing renal interstitial fibrosis
10/11/2012WO2012137610A1 Pharmaceutical preparation
10/11/2012WO2012136851A1 Methods and pharmaceutical compositions for inhibiting influenza viruses replication
10/11/2012WO2012136829A1 Novel combination treatment of cancer
10/11/2012WO2012136732A1 Treatment of multiple myeloma with masitinib
10/11/2012WO2012136659A1 Sn-1(3) monoacylglycerides and lipid absorption
10/11/2012WO2012135970A1 Inhibitors of phosphatidic acid phosphohydrolase (pap), including d-propranolol and analogs thereof, alone or in combination with desipramine, for the treatment of cancers that depend on the epidermal growth factor receptor (egfr), oncogenic variants thereof and other members of the erbb/her family
10/11/2012WO2012007159A3 Novel gastro-retentive dosage forms
10/11/2012US20120258144 SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE
10/11/2012US20120258134 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
10/11/2012US20120258043 Linkable Lewis X Analogs
10/11/2012CA2832303A1 Pharmaceutical preparation
10/11/2012CA2830028A1 Sn-1(3) monoacylglycerides and lipid absorption
10/11/2012CA2826785A1 Inhibitors of phosphatidic acid phosphohydrolase (pap), including d-propranolol and analogs thereof, alone or in combination with desipramine, for the treatment of cancers that depend on the epidermal growth factor receptor (egfr), oncogenic variants thereof and other members of the erbb/her family
10/10/2012EP2508231A2 Imidazoles for treating multi-drug resistant bacterial infections
10/10/2012EP2508204A2 Remedies for diseases caused by vascular contraction or dilation
10/10/2012EP2508191A1 Combination therapy for treatment of patients with neurological disorders and cerebral infarction
10/10/2012EP2508180A1 Sn-1(3) Monoacylglycerides and lipid absorption
10/10/2012EP2508176A1 Novel combination treatment of cancer
10/10/2012EP2506867A1 Pharmaceutical compositions for the stimulation of stem cells.
10/10/2012EP2506853A1 Combination therapy for treating cancer and diagnostic assays for use therein
10/10/2012EP2506848A1 Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof
10/10/2012EP2506844A1 Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
10/10/2012EP2506840A1 Uses of hypoxia-inducible factor inhibitors
10/10/2012EP2506814A1 Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
10/10/2012EP2506717A1 Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions
10/10/2012CN1822817B Inhalable formulations for treating pulmonary hypertension and methods of using same
10/10/2012CN1678188B Nucleic acid compositions for stimulating immune responses
10/10/2012CN1662251B Adjuvant enhanced immunotherapy
10/10/2012CN1607957B Modulation of excitable tissue function by peripherally administered erythropoietin
10/10/2012CN102724977A Fulvic acid in combination with fluconazole or amphotericin b for the treatment of fungal infections
10/10/2012CN102724974A Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
10/10/2012CN102719522A Application of acetylcholinesterase gene promoter in screening anti-hepatoma drugs
10/10/2012CN102719521A Application of cystine/glutamic acid reverse transporter xCT inhibitor in treating liver cancer
10/10/2012CN102719478A Chimpanzee adenovirus vaccine carriers
10/10/2012CN102716495A Multifunctional poly(malic acid) carried drug for targeting treatment of tumors
10/10/2012CN102716486A Slowly-releasing anticancer drug composition and application thereof
10/10/2012CN102716087A Vitamin powder and preparation method thereof
10/10/2012CN102715184A Aqueous olanexidine solution, method of preparing the same, and disinfectant
10/10/2012CN101868251B Pharmaceutical containing HIF-1alpha alpha and HIF-2alpha alpha expression inhibitor
10/10/2012CN101450934B Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/10/2012CN101400670B Novel pyridine derivative having anti-helicobacter pylori activity
1 ... 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 ... 1151